BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28793777)

  • 1. The p53 Family in Brain Disease.
    Agostini M; Melino G; Bernassola F
    Antioxid Redox Signal; 2018 Jul; 29(1):1-14. PubMed ID: 28793777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53 family: at the crossroads in cancer therapy.
    Alsafadi S; Tourpin S; André F; Vassal G; Ahomadegbe JC
    Curr Med Chem; 2009; 16(32):4328-44. PubMed ID: 19754415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Roles of p53 Family Members in Glucose Metabolism.
    Itahana Y; Itahana K
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A microRNA-dependent circuit controlling p63/p73 homeostasis: p53 family cross-talk meets therapeutic opportunity.
    Ory B; Ellisen LW
    Oncotarget; 2011 Mar; 2(3):259-64. PubMed ID: 21436470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p63 and p73: roles in development and tumor formation.
    Moll UM; Slade N
    Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic prospects for p73 and p63: rising from the shadow of p53.
    Vilgelm A; El-Rifai W; Zaika A
    Drug Resist Updat; 2008; 11(4-5):152-63. PubMed ID: 18801697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of functions within the p53/p63/p73 family.
    De Laurenzi V; Melino G
    Ann N Y Acad Sci; 2000; 926():90-100. PubMed ID: 11193045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TP53 family members and human cancers.
    Bénard J; Douc-Rasy S; Ahomadegbe JC
    Hum Mutat; 2003 Mar; 21(3):182-91. PubMed ID: 12619104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 Family isoforms.
    Bourdon JC
    Curr Pharm Biotechnol; 2007 Dec; 8(6):332-6. PubMed ID: 18289041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
    Murray-Zmijewski F; Lane DP; Bourdon JC
    Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glyoxalase II, a detoxifying enzyme of glycolysis byproduct methylglyoxal and a target of p63 and p73, is a pro-survival factor of the p53 family.
    Xu Y; Chen X
    J Biol Chem; 2006 Sep; 281(36):26702-13. PubMed ID: 16831876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox state of p63 and p73 core domains regulates sequence-specific DNA binding.
    Tichý V; Navrátilová L; Adámik M; Fojta M; Brázdová M
    Biochem Biophys Res Commun; 2013 Apr; 433(4):445-9. PubMed ID: 23501101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Diverse Functions of Mutant 53, Its Family Members and Isoforms in Cancer.
    Hall C; Muller PAJ
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of p53 with prolyl isomerases: Healthy and unhealthy relationships.
    Mantovani F; Zannini A; Rustighi A; Del Sal G
    Biochim Biophys Acta; 2015 Oct; 1850(10):2048-60. PubMed ID: 25641576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of two new members of the p53 family, p63 and p73, in extramammary Paget's disease.
    Chen S; Moroi Y; Urabe K; Takeuchi S; Kido M; Hayashida S; Uchi H; Uenotsuchi T; Tu Y; Furue M
    Clin Exp Dermatol; 2008 Aug; 33(5):634-40. PubMed ID: 18627398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles for p53 and p73 during oligodendrocyte development.
    Billon N; Terrinoni A; Jolicoeur C; McCarthy A; Richardson WD; Melino G; Raff M
    Development; 2004 Mar; 131(6):1211-20. PubMed ID: 14960496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p63 and p73 coordinate p53 function to determine the balance between survival, cell death, and senescence in adult neural precursor cells.
    Fatt MP; Cancino GI; Miller FD; Kaplan DR
    Cell Death Differ; 2014 Oct; 21(10):1546-59. PubMed ID: 24809925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p73: From the p53 shadow to a major pharmacological target in anticancer therapy.
    Ramos H; Raimundo L; Saraiva L
    Pharmacol Res; 2020 Dec; 162():105245. PubMed ID: 33069756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dominant-negative interplay between p53, p63 and p73: A family affair.
    Billant O; Léon A; Le Guellec S; Friocourt G; Blondel M; Voisset C
    Oncotarget; 2016 Oct; 7(43):69549-69564. PubMed ID: 27589690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53.
    Davison TS; Vagner C; Kaghad M; Ayed A; Caput D; Arrowsmith CH
    J Biol Chem; 1999 Jun; 274(26):18709-14. PubMed ID: 10373484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.